article · Measurement and Evaluations in Cancer Care
Health-related quality of life (HRQoL) is a critical outcome in oncology care. While numerous QoL instruments exist, their psychometric properties and cross-cultural validity have not been fully examined in Ghanaian populations. The study aimed to evaluate the reliability, factorial validity, measurement invariance, and differential item functioning (DIF) of a culturally adapted 24-item cancer QoL scale among adult oncology patients in Ghana. A cross-sectional, multi-center survey was conducted with 887 adult cancer patients across major oncology centers in Ghana. The adapted QoL scale assessed Physical, Emotional, Social, and Functional Well-Being. Analyses included descriptive statistics, internal consistency (Cronbach’s α, McDonald’s ω), confirmatory factor analysis (CFA), multi-group CFA for measurement invariance across Akan, Ewe, Northern language speakers, and other minority groups, DIF using Mantel-Haenszel, logistic regression, and item response theory. The scale demonstrated excellent reliability (α = 0.87–0.94, ω = 0.88–0.95) and acceptable factorial validity (CFI = 0.958, TLI = 0.951, RMSEA = 0.038). Configural, metric, scalar, and strict invariance were supported across cultural groups. Minor DIF was detected for Emotional Well-Being, Fatigue, and Family Support items. Latent mean comparisons indicated small variations across groups, with most domains largely comparable. The adapted 24-item cancer QoL scale is reliable, valid, and largely cross-culturally equivalent for assessing HRQoL among diverse Ghanaian oncology populations. It provides a culturally sensitive tool for clinical assessment, research, and cross-cultural comparisons.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.ymecc.2026.100031
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.